DOCSLIB.ORG

Recurrent Utis in Women: Department of Family Medicine, Uniformed Services University How You Can Refine Your Care of the Health Sciences, Bethesda, Md (Dr

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Recurrent Utis in Women: Department of Family Medicine, Uniformed Services University How You Can Refine Your Care of the Health Sciences, Bethesda, Md (Dr Jeffrey D. Quinlan, MD, FAAFP; Sarah K. Jorgensen, DO Recurrent UTIs in women: Department of Family Medicine, Uniformed Services University How you can refine your care of the Health Sciences, Bethesda, Md (Dr. Quinlan); National Which risk factors are (really) associated with Capital Consortium Family Medicine Residency recurrence? Which prophylactic and nonpharmacologic Program, Fort Belvoir Community Hospital, Va strategies are useful? This guide provides the answers. (Dr. Jorgensen) jeffrey.quinlan@usuhs. edu CASE For the third time in 9 months, 28-year-old Joan B The views expressed in this PRACTICE article are those of the authors comes into the office with complaints of painful, frequent, and and do not necessarily reflect the RECOMMENDATIONS official policy or position of the urgent urination. Ms B is sexually active and her medical history ❯ Avoid routine use of Department of Defense or the is otherwise unremarkable. In each of the previous 2 episodes, Uniformed Services University of cystoscopy and imaging the Health Sciences. her urine culture grew Escherichia coli, and she was treated when evaluating women with a 5-day course of nitrofurantoin. At this current visit, she The authors reported no with recurrent urinary potential conflict of interest B asks about the need for additional work-up, treatment for relevant to this article. tract infection (UTI). her symptoms, and whether there is a way to prevent further ❯ Keep in mind that 3- to infections. 5-day courses of antibiotics (nitrofurantoin, trimethoprim- sulfamethoxazole, fosfomycin, rinary tract infections (UTIs) are the most common 1 or beta-lactams) for UTIs are bacterial infection in women and account for an as effective as longer courses, estimated 5.4 million primary care office visits and U 2 and are associated with 2.3 million emergency room visits annually. For women, the better compliance and fewer lifetime risk of developing a UTI is greater than 50%.3 In one adverse effects. A study of UTI in a primary care setting, 36% of women under ❯ Assure patients 55 and 53% of women over 55 had a recurrent infection within considering prophylaxis a year.4 Most women with UTI are treated as outpatients, but for recurrent UTI that either 16.7% require hospitalization.5 In the United States, direct costs continuous or postcoital for evaluation and treatment of UTI total $1.6 billion each year.5 antibiotics are effective. A Strength of recommendation (SOR) Accurately characterizing recurrent UTI 5 A Good-quality patient-oriented Bacteriuria is defined as the presence of 10 colony form- evidence ing units (ie, viable bacteria) per milliliter of urine collected B Inconsistent or limited-quality midstream on 2 consecutive urinations.6 UTIs are symptom- patient-oriented evidence atic infections of the urinary tract and may involve the ure- C Consensus, usual practice, opinion, disease-oriented thra, bladder, ureters, or kidneys.7 Infections of the lower tract evidence, case series (bladder and urethra) are commonly referred to as cystitis; infections of the upper tract (kidney and ureters) are referred to as pyelonephritis. Most UTIs are uncomplicated and do not progress to more serious infections. However, patients who are pregnant, have chronic medical conditions (eg, renal insufficiency or use of immunosuppressant medications), urinary obstruction, or calculi may develop complicated UTIs.8 94 THE JOURNAL OF FAMILY PRACTICE | FEBRUARY 2017 | VOL 66, NO 2 ❚ Recurrent UTI is an infection that fol- in relative risk for UTI.15 Those who had daily lows resolution of bacteriuria and symptoms intercourse had a 9-fold increase in relative of a prior UTI, and the term applies when risk of UTI development.15 This elevated risk such an infection occurs within 6 months of is due to trauma to the lower urogenital tract the last UTI or when 3 or more UTIs occur (urethra) and introduction of bacteria into within a year.7 Recurrent infection can be fur- the urethra via mechanical factors.16,17 ther characterized as relapse or reinfection. Relapse occurs when the patient has a sec- Postmenopausal women ond UTI caused by the same pathogen within Atrophic vaginitis, catheterization, declin- 2 weeks of the original treatment.9 Reinfec- ing functional status, cystocele, incomplete tion is a UTI that occurs more than 2 weeks emptying, incontinence, and history of after completion of treatment for the original premenopausal UTIs are all risk factors for UTI. The pathogen in a reinfection may be recurrent UTI in postmenopausal women.19,20 the same one that caused the original UTI or Decreased estrogen and resulting vaginal it may be a different agent.9 atrophy appear to be associated with It’s also important to differentiate between increased rates of UTI in these women. recurrent and resistant UTI. In resistant UTI, Additionally, postmenopausal women’s bacteriuria fails to resolve following 7 to vaginas are more likely to be colonized with 14 days of appropriate antibiotic treatment.9 E coli and have fewer lactobacilli than those of premenopausal women,21 which is thought Neither to predispose them to UTI. These risk factors cystoscopy Factors that increase the risk are summarized in TABLE 1.10-21 nor imaging of recurrent UTI is routinely Premenopausal women recommended Both modifiable and non-modifiable fac- Initial evaluation of recurrent UTI for the tors (TABLE 110-21) have been associated with Patients with recurrent UTI experience signs evaluation increased risk of recurrent UTI in premeno- and symptoms similar to those with isolated of recurrent pausal women. Among women with specific uncomplicated UTI: dysuria, frequency, urinary tract blood group phenotypes (Lewis non-secretor, urgency, and hematuria. Focus your history infection. in particular), rates of UTI rise secondary to interview on potential causes of complicated increased adherence of bacteria to epithe- UTI (TABLE 218). Likewise, perform a pelvic lial cells in the urinary tract.10 Other non- examination to evaluate for predisposing modifiable risk factors include congenital anatomic abnormalities.22 Finally, obtain a urinary tract anomalies, obstruction of the urine culture with antibiotic sensitivities to urinary tract, and a history of UTI.11,12 Women ensure that previous treatment was appropri- whose mothers had UTIs are at higher risk for ate and to rule out microbes associated with recurrent UTI than are women whose moth- infected uroliths.18 Given the low probabil- ers had no such history.13 ity of finding abnormalities on cystoscopy or Modifiable risk factors for recurrent imaging, neither one is routinely recom- UTI include contraceptive use (spermicides, mended for the evaluation of recurrent UTI.18 spermicide-coated condoms, and oral con- traceptives) and frequency of intercourse (≥4 times/month).13 Spermicides alter the Treatment options and precautions normal vaginal flora and lead to increased As with isolated UTI, E coli is the most colonization of E coli, which increases the common pathogen in recurrent UTI. risk for UTI.14 Women with recurrent UTIs However, recurrent UTI is more likely than iso- were 1.27 to 1.45 times more likely to use oral lated UTI to result from other pathogens (odds contraceptives than those without recurrent ratio [OR]=1.5; 95% confidence interval [CI], UTIs.13 Compared with college women who 1.0-2.26), such as Klebsiella, Enterococcus, had not had intercourse during the week, sex- Proteus, and Citrobacter.23 Since a patient’s ually active college women who had engaged recurrent UTI most likely arises from the in intercourse 3 times had a 2.6-fold increase same pathogen that caused the prior infec- JFPONLINE.COM VOL 66, NO 2 | FEBRUARY 2017 | THE JOURNAL OF FAMILY PRACTICE 95 TABLE 1 for 5 days has effi- Risk factors for recurrent UTIs in women10-21 cacy similar to that of TMP-SMX, but with- Premenopausal women out significant bacte- Modifiable Non-modifiable rial resistance. While fosfomycin 3 g as a Contraceptive use Lewis non-secretor blood type single dose is still rec- • Spermicides ommended as first- • Spermicide-coated condoms line treatment, it is • Oral contraceptives less effective than either TMP-SMX or Intercourse ≥4 times/month Congenital urinary tract anomalies nitrofurantoin. TABLE 324 Urinary tract obstruction summarizes these History of UTI in the patient or her ant ibiotic choices and mother their efficacies. ❚ Agents to avoid Postmenopausal women or use only as a last Atrophic vaginitis History of premenopausal UTI resort. For patients Cystocele Catheterization unable to take any of With recurrent Incontinence Declining functional status the drugs above, con- UTI, start sider beta-lactam anti- an antibiotic Incomplete emptying biotics, although they that's effective Not proven to be associated with UTI in pre- or postmenopausal women are typically less effec- against Postcoital voiding habits tive for this indication. the organism While fluoroquino- cultured during Douching lones are very effec- the prior Caffeine consumption tive and have low (but infection. Bubble baths rising) resistance rates, they are also associ- Sexually transmitted infections ated with serious and Body mass index potentially permanent Non-cotton underwear adverse effects. As a result, on May 12, 2016, Chronic disease the Food and Drug UTI, urinary tract infection. Administration issued a Drug Safety Com- munication recom- tion,8 start an antibiotic you know is effec- mending that fluoroquinolones be used only tive against it. Additionally, take into account in patients without other treatment options.24,25 local resistance rates; antibiotic availability, Do not use ampicillin or amoxicillin, which lack cost, and adverse effects; and a patient’s drug effectiveness for this indication and are com- allergies. promised by high levels of bacterial resistance. ❚ Preferred antibiotics. Trimethoprim- ❚ Shorter course of treatment? When de- sulfamethoxazole (TMP-SMX), 160 mg/800 ciding on the length of treatment for recurrent mg twice daily for 3 days, has long been the UTI, remember that shorter antibiotic courses mainstay of treatment for uncomplicated (3-5 days) are associated with similar rates of UTI.
Load more

Recommended publications
  • 3-Year Results of Transvaginal Cystocele Repair with Transobturator Four-Arm Mesh: a Prospective Study of 105 Patients
    Arab Journal of Urology (2014) 12, 275–284 Arab Journal of Urology (Official Journal of the Arab Association of Urology) www.sciencedirect.com ORIGINAL ARTICLE 3-year results of transvaginal cystocele repair with transobturator four-arm mesh: A prospective study of 105 patients Moez Kdous *, Fethi Zhioua Department of Obstetrics and Gynecology, Aziza Othmana Hospital, Tunis, Tunisia Received 27 January 2014, Received in revised form 1 May 2014, Accepted 24 September 2014 Available online 11 November 2014 KEYWORDS Abstract Objectives: To evaluate the long-term efficacy and safety of transobtura- tor four-arm mesh for treating cystoceles. Genital prolapse; Patients and methods: In this prospective study, 105 patients had a cystocele cor- Cystocele; rected between January 2004 and December 2008. All patients had a symptomatic Transvaginal mesh; cystocele of stage P2 according to the Baden–Walker halfway stratification. We Polypropylene mesh used only the transobturator four-arm mesh kit (SurgimeshÒ, Aspide Medical, France). All surgical procedures were carried out by the same experienced surgeon. ABBREVIATIONS The patients’ characteristics and surgical variables were recorded prospectively. The VAS, visual analogue anatomical outcome, as measured by a physical examination and postoperative scale; stratification of prolapse, and functional outcome, as assessed by a questionnaire TOT, transobturator derived from the French equivalents of the Pelvic Floor Distress Inventory, Pelvic tape; Floor Impact Questionnaire and the Pelvic Organ Prolapse–Urinary Incontinence- TVT, tension-free Sexual Questionnaire, were considered as the primary outcome measures. Peri- vaginal tape; and postoperative complications constituted the secondary outcome measures. TAPF, tendinous arch Results: At 36 months after surgery the anatomical success rate (stage 0 or 1) was of the pelvic fascia; 93%.
    [Show full text]
  • Complications of Incontinence and Prolapse Surgery: Evaluation, Intervention, and Resolution—A Review from Both Specialties W42, 16 October 2012 14:00 - 18:00
    Complications of Incontinence and Prolapse Surgery: Evaluation, Intervention, and Resolution—A Review from Both Specialties W42, 16 October 2012 14:00 - 18:00 Start End Topic Speakers 14:00 14:10 Introduction Howard Goldman 14:10 14:35 Complications of incontinence surgery (except Sandip Vasavada retention) 14:35 15:10 Retention/Voiding dysfunction after incontinence Roger Dmochowski surgery 15:10 15:30 Discussion All 15:30 16:00 Break None 16:00 16:35 Complications of prolapse surgery (except Howard Goldman dyspareunia) 16:35 17:00 Dyspareunia after pelvic floor surgery Tristi Muir 17:00 17:40 Discussion All 17:40 18:00 Questions All Aims of course/workshop This course will summarize both common and uncommon complications associated with standard and new technologies used for pelvic floor reconstruction and urinary incontinence therapy in women. The intent of this course is to present both the approach to evaluation and management of these complications from both the urologic and urogynecologic perspective of the combined faculty. The emphasis is on newer technologies and complications, both acute and chronic, which are associated with these various surgeries. The goal of this course will be to summarize, not only identification, but also evaluation and appropriate intervention, as well as patient counselling for these various complications. Educational Objectives This course will provide a detailed paradigm for avoiding, evaluating and managing complications of incontinence and prolapse surgery. Evidence continues to accrue in this area but it runs the spectrum from Level 1 to 5 with much being expert opinion. Unfortunately, very little cross comparison exists to support these differing interventions.
    [Show full text]
  • Pessary Information
    est Ridge obstetrics & gynecology, LLP 3101 West Ridge Road, Rochester, NY 14626 1682 Empire Boulevard, Webster, NY 14580 www.wrog.org Tel. (585) 225‐1580 Fax (585) 225‐2040 Tel. (585) 671‐6790 Fax (585) 671‐1931 USE OF THE PESSARY The pessary is one of the oldest medical devices available. Pessaries remain a useful device for the nonsurgical treatment of a number of gynecologic conditions including pelvic prolapse and stress urinary incontinence. Pelvic Support Defects The pelvic organs including the bladder, uterus, and rectum are held in place by several layers of muscles and strong tissues. Weaknesses in this tissue can lead to pelvic support defects, or prolapse. Multiple vaginal deliveries can weaken the tissues of the pelvic floor. Weakness of the pelvic floor is also more likely in women who have had a hysterectomy or other pelvic surgery, or in women who have conditions that involve repetitive bearing down, such as chronic constipation, chronic coughing or repetitive heavy lifting. Although surgical repair of certain pelvic support defects offers a more permanent solution, some patients may elect to use a pessary as a very reasonable treatment option. Classification of Uterine Prolapse: Uterine prolapse is classified by degree. In first‐degree uterine prolapse, the cervix drops to just above the opening of the vagina. In third‐degree prolapse, or procidentia, the entire uterus is outside of the vaginal opening. Uterine prolapse can be associated with incontinence. Types of Vaginal Prolapse: . Cystocele ‐ refers to the bladder falling down . Rectocele ‐ refers to the rectum falling down . Enterocele ‐ refers to the small intestines falling down .
    [Show full text]
  • Legacy Health
    Legacy Health Co-Management and Referral Guidelines Management of Pelvic Floor Dysfunction Phone: 503-413-3707 Legacy Physical Therapy Fax: 503-413-1504 Introduction After appropriate evaluation by your care providers, patients may be referred to pelvic floor physical therapy for management of pelvic floor muscle dysfunctions/pain, incontinence of urine or fecal matter, pelvic floor/girdle physical therapy. • Hypertonic pelvic floor dysfunction — vaginismus, dyspareunia, levator ani syndrome • Hypotonic pelvic floor muscles — organ prolapse, rectus diastasis • Continence issues after abdominal surgeries in male and female (prostate or hysterectomies), overactive bladder • Endometriosis, pelvic pain • Chronic constipation Evaluation Evaluation and A careful history and evaluation/physical exam will be performed to assess the origin and functional Management limitations of the patient. Muscle tone assessment, organ mobility, scar tissue mobility, bladder and/or bowel diary Treatment Strengthening or down-training PF muscles, with or without biofeedback, manual therapy, scar tissue release, electrical stimulation, trigger point release, visceral and myofascial mobilization, body mechanics and core stabilization. Duration One to six 60-minute visits with the physical therapist When to refer Refer when pain is limiting normal activities of daily living, if patient is not able to get to the bathroom dry, if sexual activity is painful (although dyspareunia alone is often not covered by insurance) Commonly referred ICD10 codes and descriptors for PT diagnoses R10.9 Abdominal pain K59.4 Anal spasm/proctalgia fugax R39.89 Bladder pain M53.3 Coccygodynia K59.00 Constipation, unspecified N81.10 Cystocele, unspecified (prolapse of anterior vaginal wall NOS) M62.0 Diastasis rectus post-partum N94.1 Dyspareunia — excludes psychogenic dyspareunia (F52.6).
    [Show full text]
  • Pelvic Floor Ultrasound in Prolapse: What's in It for the Surgeon?
    Int Urogynecol J (2011) 22:1221–1232 DOI 10.1007/s00192-011-1459-3 REVIEW ARTICLE Pelvic floor ultrasound in prolapse: what’s in it for the surgeon? Hans Peter Dietz Received: 1 March 2011 /Accepted: 10 May 2011 /Published online: 9 June 2011 # The International Urogynecological Association 2011 Abstract Pelvic reconstructive surgeons have suspected technique became an obvious alternative, whether via the for over a century that childbirth-related trauma plays a transperineal [4, 5] (see Fig. 1) or the vaginal route [6]. major role in the aetiology of female pelvic organ prolapse. More recently, magnetic resonance imaging has also Modern imaging has recently allowed us to define and developed as an option [7], although the difficulty of reliably diagnose some of this trauma. As a result, imaging obtaining functional information, and cost and access is becoming increasingly important, since it allows us to problems, have hampered its general acceptance. identify patients at high risk of recurrence, and to define Clinical examination techniques, in particular if the underlying problems rather than just surface anatomy. examiner is insufficiently aware of their inherent short- Ultrasound is the most appropriate form of imaging in comings, are rather inadequate tools with which to assess urogynecology for reasons of cost, access and performance, pelvic floor function and anatomy. This is true even if one and due to the fact that it provides information in real time. uses the most sophisticated system currently available, the I will outline the main uses of this technology in pelvic prolapse quantification system of the International Conti- reconstructive surgery and focus on areas in which the nence Society (ICS Pelvic Organ Prolapse Quantification benefit to patients and clinicians is most evident.
    [Show full text]
  • The Effects of a Life-Stress Interview for Women with Chronic Urogenital Pain: a Randomized Trial" (2016)
    Wayne State University Wayne State University Dissertations 1-1-2016 The ffecE ts Of A Life-Stress Interview For Women With Chronic Urogenital Pain: A Randomized Trial Jennifer Carty Wayne State University, Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations Part of the Clinical Psychology Commons Recommended Citation Carty, Jennifer, "The Effects Of A Life-Stress Interview For Women With Chronic Urogenital Pain: A Randomized Trial" (2016). Wayne State University Dissertations. Paper 1521. This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState. THE EFFECTS OF A LIFE-STRESS INTERVIEW FOR WOMEN WITH CHORNIC UROGENITAL PAIN: A RANDOMIZED TRAIL by JENNIFER N. CARTY DISSERTATION Submitted to the Graduate School of Wayne State University, Detroit, Michigan in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY 2016 MAJOR: PSYCHOLOGY (Clinical) Approved By: ______________________________ Advisor Date ______________________________ ______________________________ ______________________________ ACKNOWLEDGEMENTS I am immensely grateful to many people for their contributions to this project and my professional and personal development. First, I would like to thank my advisor, Dr. Mark Lumley, for his guidance and support in the development of this project, and for both encouraging and challenging me throughout my academic career, for which I will always be grateful. I would also like to thank Dr. Janice Tomakowsky, Dr. Kenneth Peters, and the medical providers, physical therapists, and staff at the Women’s Urology Center at Beaumont Hospital for graciously allowing me to conduct this study at their clinic and with their patients.
    [Show full text]
  • Uro 2018-159 Issue Date: 02/2015 Review Date: 03/2021 © Liverpool Women’S NHS Foundation Trust
    Vaginal Pessary Information Leaflet What Is A Pessary? A pessary is a plastic or silicone device that fits into your vagina to support a prolapsed bladder, rectum or uterus (womb). There are different types but the most commonly used are either a ring or a shelf pessary. 71%- 90% of women are successfully fitted with a pessary. What Is A Prolapse? A prolapse means that your uterus, bladder or rectum is bulging or leaning into the vagina, because the muscular walls of the vagina have become weakened. This can sometimes be felt as a lump in the vagina. If the prolapse is large it may also cause difficulty when emptying the bladder or bowel. It is possible for women to have more than one type of prolapse. 50% of women can get a prolapse. Patients can have varying symptoms such as vaginal heaviness, pelvic pressure bulging into the vagina and backache. What Are The Different Types Of Prolapse? Cystocele A cystocele occurs when the vaginal wall that is next to the bladder becomes weakened. This causes the bladder to lean (or prolapse) into the vagina, where it may then be felt as a lump (See Figure 1) Cystocele Figure 1 Rectocele A rectocele occurs when the vaginal wall next to the rectum becomes weakened. This causes the rectum to lean (or prolapse) into the vagina, where it may then be felt as a lump. This type of prolapse may cause difficulty when opening your bowels. (See Figure 2) Figure 2 Uterine prolapse A Uterine prolapse occurs when the structures that support the womb weaken.
    [Show full text]
  • Differential Diagnosis of Endometriosis by Ultrasound
    diagnostics Review Differential Diagnosis of Endometriosis by Ultrasound: A Rising Challenge Marco Scioscia 1 , Bruna A. Virgilio 1, Antonio Simone Laganà 2,* , Tommaso Bernardini 1, Nicola Fattizzi 1, Manuela Neri 3,4 and Stefano Guerriero 3,4 1 Department of Obstetrics and Gynecology, Policlinico Hospital, 35031 Abano Terme, PD, Italy; [email protected] (M.S.); [email protected] (B.A.V.); [email protected] (T.B.); [email protected] (N.F.) 2 Department of Obstetrics and Gynecology, “Filippo Del Ponte” Hospital, University of Insubria, 21100 Varese, VA, Italy 3 Obstetrics and Gynecology, University of Cagliari, 09124 Cagliari, CA, Italy; [email protected] (M.N.); [email protected] (S.G.) 4 Department of Obstetrics and Gynecology, Azienda Ospedaliero Universitaria, Policlinico Universitario Duilio Casula, 09045 Monserrato, CA, Italy * Correspondence: [email protected] Received: 6 October 2020; Accepted: 15 October 2020; Published: 20 October 2020 Abstract: Ultrasound is an effective tool to detect and characterize endometriosis lesions. Variances in endometriosis lesions’ appearance and distorted anatomy secondary to adhesions and fibrosis present as major difficulties during the complete sonographic evaluation of pelvic endometriosis. Currently, differential diagnosis of endometriosis to distinguish it from other diseases represents the hardest challenge and affects subsequent treatment. Several gynecological and non-gynecological conditions can mimic deep-infiltrating endometriosis. For example, abdominopelvic endometriosis may present as atypical lesions by ultrasound. Here, we present an overview of benign and malignant diseases that may resemble endometriosis of the internal genitalia, bowels, bladder, ureter, peritoneum, retroperitoneum, as well as less common locations. An accurate diagnosis of endometriosis has significant clinical impact and is important for appropriate treatment.
    [Show full text]
  • Vulvovaginal Atrophy: a Common—And Commonly Overlooked— Problem Mary H
    The Warren Alpert Medical School of Brown University GERI A TRI C S FOR THE Division of Geriatrics PR ac TI C ING PHYSICIAN Quality Partners of RI Department of Medicine EDITED B Y AN A Tuya FU LTON , MD Vulvovaginal Atrophy: A Common—and Commonly Overlooked— Problem Mary H. Hohenhaus, MD, FACP Mrs. K is a 67-year-old woman presenting for a brief All postmenopausal women are at risk for vaginal atrophy. follow-up visit. You treated her for an E. coli urinary Smokers are more estrogen deficient compared with nonsmok- tract infection last month, but she feels well today and ers and may be at higher risk. Engaging in regular sexual activ- offers no complaints. Her blood pressure and lipids ity, whether through intercourse or masturbation, appears to are well controlled on low doses of a single antihyper- decrease risk, possibly through increased blood flow. Women tensive and a lipid lowering agent. She still struggles using anti-estrogen medications, such as aromatase inhibitors with smoking, but has cut down to a few cigarettes a for adjuvant treatment of breast cancer, are more likely to experi- day. She also reports her husband has finally turned ence severe symptoms. over the family business to their children, and they Women may not volunteer symptoms related to vulvovagi- are enjoying spending more time together. When you nal atrophy. The symptomatic woman can experience vaginal ask if there is anything else she needs, she hesitates dryness, burning, and pruritus; yellow, malodorous discharge; for a moment before asking, “Is there anything I can urinary frequency and urgency; and pain during intercourse and do to make sex more comfortable?” bloody spotting afterward.
    [Show full text]
  • Ask the Expert - Answers
    Ask the Expert - Answers Q. I had a hysterectomy four years ago. Since then, I have been experiencing progressively increasing urgency. I drink one XL cup of coffee per day but when I have to go, I have to go and you better get out of my way. I remember speaking with my gynecologist about the possibility of my bladder dropping when she explained the procedure, risks, etc. Is it possible that this is what's happening to me? A. You're describing urinary urgency and it's a common and frustrating symptom. There are many conditions that cause this symptom with the most common being bladder infections and overactive bladder. There are other much less common causes. In general, a "dropped bladder" or a cystocele doesn't cause urinary urgency or urge incontinence. Cystoceles are usually associated with stress urinary incontinence (leakage of urine with coughing, laughing, sneezing or physical activity). While surgery can often repair a cystocele and help stress incontinence, repairing a cystocele or dropped bladder doesn't usually cure urinary urgency. The good news is that urinary urgency can often be greatly improved with simple nonsurgical approaches. We encourage you to see a specialist who should be able to help make this problem much better. Q. I am 62 years old and have had urine leakage for the past few years. I use to wear a Kotex pad but they would not be able to hold the urine so I switched over to Tena Pads which work well. I need to change the pad two times a day and it is full.
    [Show full text]
  • SURGICAL TUTORIAL 1: Before, During and After- Comprehensive Team Approach to Laparoscopic Management of Severe Endometriosis
    SYLLABUS SURGICAL TUTORIAL 1: Before, During and After- Comprehensive Team Approach to Laparoscopic Management of Severe Endometriosis Be a Surgical “Multiplier” in MIGS Inspire Brilliance Through Teamwork Scientific Program Chair Honorary Chair President Jubilee Brown, MD Barbara S. Levy, MD Marie Fidela R. Paraiso, MD Professional Education Information Target Audience This educational activity is developed to meet the needs of surgical gynecologists in practice and in training, as well as other healthcare professionals in the field of gynecology. Accreditation AAGL is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AAGL designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Disclosure of Relevant Financial Relationships As a provider accredited by the Accreditation Council for Continuing Medical Education, AAGL must ensure balance, independence, and objectivity in all CME activities to promote improvements in health care and not proprietary interests of a commercial interest. The provider controls all decisions related to identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the activity. Course chairs, planning committee members, presenters, authors, moderators, panel members, and others in a position to control the content of this activity are required to disclose relevant financial relationships with commercial interests related to the subject matter of this educational activity.
    [Show full text]
  • Gynecological Conditions Disability Benefits Questionnaire
    GYNECOLOGICAL CONDITIONS DISABILITY BENEFITS QUESTIONNAIRE NAME OF PATIENT/VETERAN PATIENT/VETERAN'S SOCIAL SECURITY NUMBER IMPORTANT - THE DEPARTMENT OF VETERANS AFFAIRS (VA) WILL NOT PAY OR REIMBURSE ANY EXPENSES OR COST INCURRED IN THE PROCESS OF COMPLETING AND/OR SUBMITTING THIS FORM. Note - The Veteran is applying to the U.S. Department of Veterans Affairs (VA) for disability benefits. VA will consider the information you provide on this questionnaire as part of their evaluation in processing the Veteran's claim. VA may obtain additional medical information, including an examination, if necessary, to complete VA's review of the veteran's application. VA reserves the right to confirm the authenticity of ALL questionnaires completed by providers. It is intended that this questionnaire will be completed by the Veteran's provider. Are you completing this Disability Benefits Questionnaire at the request of: Veteran/Claimant Other, please describe, Are you a VA Healthcare provider? Yes No Is the Veteran regularly seen as a patient in your clinic? Yes No Was the Veteran examined in person? Yes No If no, how was the examination conducted? EVIDENCE REVIEW Evidence reviewed: No records were reviewed Records reviewed Please identify the evidence reviewed (e.g. service treatment records, VA treatment records, private treatment records) and the date range. Gynecological Conditions Disability Benefits Questionnaire Updated on April 16, 2020 ~v20_1 Released March 2021 Page 1 of 8 SECTION I - DIAGNOSIS 1A. LIST THE CLAIMED GYNECOLOGICAL CONDITION(S) THAT PERTAIN TO THIS DBQ: NOTE: These are the diagnoses determined during this current evaluation of the claimed condition(s) listed above.
    [Show full text]